These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32210304)

  • 1. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses.
    Hrdý J; Alard J; Couturier-Maillard A; Boulard O; Boutillier D; Delacre M; Lapadatescu C; Cesaro A; Blanc P; Pot B; Ryffel B; Chamaillard M; Grangette C
    Sci Rep; 2020 Mar; 10(1):5345. PubMed ID: 32210304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis.
    Hrdý J; Couturier-Maillard A; Boutillier D; Lapadatescu C; Blanc P; Procházka J; Pot B; Ryffel B; Grangette C; Chamaillard M
    Sci Rep; 2022 Oct; 12(1):17591. PubMed ID: 36266398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of TNBS-induced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes.
    Roselli M; Finamore A; Nuccitelli S; Carnevali P; Brigidi P; Vitali B; Nobili F; Rami R; Garaguso I; Mengheri E
    Inflamm Bowel Dis; 2009 Oct; 15(10):1526-36. PubMed ID: 19504616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social stress-enhanced severity of Citrobacter rodentium-induced colitis is CCL2-dependent and attenuated by probiotic Lactobacillus reuteri.
    Mackos AR; Galley JD; Eubank TD; Easterling RS; Parry NM; Fox JG; Lyte M; Bailey MT
    Mucosal Immunol; 2016 Mar; 9(2):515-26. PubMed ID: 26422754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of dendritic cells by Lactobacillus reuteri surface components and metabolites.
    Engevik MA; Ruan W; Esparza M; Fultz R; Shi Z; Engevik KA; Engevik AC; Ihekweazu FD; Visuthranukul C; Venable S; Schady DA; Versalovic J
    Physiol Rep; 2021 Jan; 9(2):e14719. PubMed ID: 33463911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri.
    Gao C; Major A; Rendon D; Lugo M; Jackson V; Shi Z; Mori-Akiyama Y; Versalovic J
    mBio; 2015 Dec; 6(6):e01358-15. PubMed ID: 26670383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probiotics Lactobacillus acidophilus on Citrobacter rodentium colitis: the role of dendritic cells.
    Chen CC; Chiu CH; Lin TY; Shi HN; Walker WA
    Pediatr Res; 2009 Feb; 65(2):169-75. PubMed ID: 19262293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice.
    Rodrigues DM; Sousa AJ; Johnson-Henry KC; Sherman PM; Gareau MG
    J Infect Dis; 2012 Jul; 206(1):99-109. PubMed ID: 22430833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotic Lactobacillus reuteri attenuates the stressor-enhanced severity of Citrobacter rodentium infection.
    Mackos AR; Eubank TD; Parry NM; Bailey MT
    Infect Immun; 2013 Sep; 81(9):3253-63. PubMed ID: 23798531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live and heat-killed probiotic Lactobacillus casei Lbs2 protects from experimental colitis through Toll-like receptor 2-dependent induction of T-regulatory response.
    Thakur BK; Saha P; Banik G; Saha DR; Grover S; Batish VK; Das S
    Int Immunopharmacol; 2016 Jul; 36():39-50. PubMed ID: 27107798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic mixture supplementation in the preventive management of trinitrobenzenesulfonic acid-induced inflammation in a murine model.
    Traina G; Menchetti L; Rappa F; Casagrande-Proietti P; Barbato O; Leonardi L; Carini F; Piro F; Brecchia G
    J Biol Regul Homeost Agents; 2016; 30(3):895-901. PubMed ID: 27655518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic Syngut on experimental colitis under stress conditions.
    Konturek PC; Konturek K; Brzozowski T; Wojcik D; Magierowski M; Targosz A; Krzysiek-Maczka G; Sliwowski Z; Strzalka M; Magierowska K; Szczyrk U; Kwiecien S; Ptak-Belowska A; Neurath M; Dieterich W; Wirtz S; Zopf Y
    J Physiol Pharmacol; 2020 Jun; 71(3):. PubMed ID: 32991312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FolC2-mediated folate metabolism contributes to suppression of inflammation by probiotic Lactobacillus reuteri.
    Thomas CM; Saulnier DM; Spinler JK; Hemarajata P; Gao C; Jones SE; Grimm A; Balderas MA; Burstein MD; Morra C; Roeth D; Kalkum M; Versalovic J
    Microbiologyopen; 2016 Oct; 5(5):802-818. PubMed ID: 27353144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide.
    Macho Fernandez E; Valenti V; Rockel C; Hermann C; Pot B; Boneca IG; Grangette C
    Gut; 2011 Aug; 60(8):1050-9. PubMed ID: 21471573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner.
    Srutkova D; Schwarzer M; Hudcovic T; Zakostelska Z; Drab V; Spanova A; Rittich B; Kozakova H; Schabussova I
    PLoS One; 2015; 10(7):e0134050. PubMed ID: 26218526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri.
    Hemarajata P; Gao C; Pflughoeft KJ; Thomas CM; Saulnier DM; Spinler JK; Versalovic J
    J Bacteriol; 2013 Dec; 195(24):5567-76. PubMed ID: 24123819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with Bifidobacterium bifidum 17 partially protects mice from Th1-driven inflammation in a chemically induced model of colitis.
    Philippe D; Heupel E; Blum-Sperisen S; Riedel CU
    Int J Food Microbiol; 2011 Sep; 149(1):45-9. PubMed ID: 21257218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lactobacillus fermentum ACA-DC 179 displays probiotic potential in vitro and protects against trinitrobenzene sulfonic acid (TNBS)-induced colitis and Salmonella infection in murine models.
    Zoumpopoulou G; Foligne B; Christodoulou K; Grangette C; Pot B; Tsakalidou E
    Int J Food Microbiol; 2008 Jan; 121(1):18-26. PubMed ID: 18077037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New probiotic strains for inflammatory bowel disease management identified by combining in vitro and in vivo approaches.
    Alard J; Peucelle V; Boutillier D; Breton J; Kuylle S; Pot B; Holowacz S; Grangette C
    Benef Microbes; 2018 Feb; 9(2):317-331. PubMed ID: 29488412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifidobacterium infantis attenuates colitis by regulating T cell subset responses.
    Zuo L; Yuan KT; Yu L; Meng QH; Chung PC; Yang DH
    World J Gastroenterol; 2014 Dec; 20(48):18316-29. PubMed ID: 25561798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.